will have no significant effect on our sales of clozapine." But just in case, the company has launched a lawsuit against Novartis. "I did this study because I wanted to know if one drug is ...
FDA Makes Access to Clozapine Easier for Patients With Schizophrenia By Stephanie Brown HealthDay Reporter FRIDAY, Feb. 28, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback